InDex Pharmaceuticals Holding AB's total assets for Q4 2025 were kr3.40B, a decrease of -13.59% from the previous quarter. SE:FLERIE total liabilities were kr20.30M for the fiscal quarter, a 51.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.